Bluemlein, K.; Glückmann, M.; Grüning, N.-M.; Feichtinger, R.; Krueger, A.; Wamelink6,, M.; Lehrach, H.; Tate, S.; Neureiter, D.; Kofler, B. et al.; Ralser, M.: Pyruvate kinase is a dosage-dependent regulator of cellular amino acid homeostasis. Oncotarget 3 (11), S. 1356 - 1356 (2012)

Bluemlein, K.; Glückmann, M.; Grüning, N.-M.; Feichtinger, R.; Krüger, A.; Wamelink, M.; Lehrach, H.; Tate, S.; Neureiter, D.; Kofler, B. et al.; Ralser, M.: Pyruvate kinase is a dosage-dependent regulator of cellular amino acid homeostasis. Oncotarget 3 (11), S. 1356 - 1369 (2012)

Börno, S.; Fischer, A.; Kerick, M.; Falth, M.; Laible, M.; Brase, J. C.; Kuner, R.; Dahl, A.; Grimm, C.; Sayanjali, B. et al.; Isau, M.; Röhr, C.; Wunderlich, A.; Timmermann, B.; Claus, R.; Plass, C.; Graefen, M.; Simon, R.; Demichelis, F.; Rubin, M. A.; Sauter, G.; Schlomm, T.; Sültmann, H.; Lehrach, H.; Schweiger, M. R.: Genome-wide DNA methylation events in TMPRSS2-ERG fusion-negative prostate cancers implicate an EZH2-dependent mechanism with miR-26a hypermethylation. Cancer Discovery 2 (11), S. 1024 - 1035 (2012)

Sharma, M.; Ioannidis, J. P.; Aasly, J. O.; Annesi, G.; Brice, A.; Bertram, L.; Bozi, M.; Barcikowska, M.; Crosiers, D.; Clarke, C. E. et al.; Facheris, M. F.; Farrer, M.; Garraux, G.; Gispert, S.; Auburger, G.; Vilarino-Guell, C.; Hadjigeorgiou, G. M.; Hicks, A. A.; Hattori, N.; Jeon, B. S.; Jamrozik, Z.; Krygowska-Wajs, A.; Lesage, S.; Lill, C. M.; Lin, J. J.; Lynch, T.; Lichtner, P.; Lang, A. E.; Libioulle, C.; Murata, M.; Mok, V.; Jasinska-Myga, B.; Mellick, G. D.; Morrison, K. E.; Meitnger, T.; Zimprich, A.; Opala, G.; Pramstaller, P. P.; Pichler, I.; Park, S. S.; Quattrone, A.; Rogaeva, E.; Ross, O. A.; Stefanis, L.; Stockton, J. D.; Satake, W.; Silburn, P. A.; Strom, T. M.; Theuns, J.; Tan, E. K.; Toda, T.; Tomiyama, H.; Uitti, R. J.; Van Broeckhoven, C.; Wirdefeldt, K.; Wszolek, Z.; Xiromerisiou, G.; Yomono, H. S.; Yueh, K. C.; Zhao, Y.; Gasser, T.; Maraganore, D.; Krüger, R.: A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants. Journal of Medical Genetics (London) 49 (11), S. 721 - 726 (2012)

Sudheer, S.; Bhushan, R.; Fauler, B.; Lehrach, H.; Adjaye, J.: FGF inhibition directs BMP4-mediated differentiation of human embryonic stem cells to syncytiotrophoblast. Stem Cells and Development 21 (16), S. 2987 - 3000 (2012)

Wollrab, C.; Heitkam, T.; Holtgrawe, D.; Weisshaar, B.; Minoche, A. E.; Dohm, J. C.; Himmelbauer, H.; Schmidt, T.: Evolutionary reshuffling in the Errantivirus lineage Elbe within the Beta vulgaris genome. The Plant Journal 72 (4), S. 636 - 51 (2012)

Kamburov, A.; Grossmann, A.; Herwig, R.; Stelzl, U.: Cluster-based assessment of protein-protein interaction confidence. BMC Bioinformatics, S. 13:262 - 13:262 (2012)

Rubelt, F.; Sievert, V.; Knaust, F.; Diener, C.; Lim, T. S.; Klipp, E.; Reinhardt, R.; Lehrach, H.; Konthur, Z.: Onset of Immune Senescence Defined by Unbiased Pyrosequencing of Human Immunoglobulin mRNA Repertoires. PLoS One (angenommen)

Moschidou, D.; Mukherjee, S.; Blundell, M. P.; Drews, K.; Jones, G. N.; Abdulrazzak, H.; Nowakowska, B.; Phoolchund, A.; Lay, K.; Ramasamy, T. S. et al.; Cananzi, M.; Nettersheim, D.; Sullivan, M.; Frost, J.; Moore, G.; Vermeesch, J. R.; Fisk, N. M.; Thrasher, A. J.; Atala, A.; Adjaye, J.; Schorle, H.; De Coppi, P.; Guillot, P. V.: Valproic acid confers functional pluripotency to human amniotic fluid stem cells in a transgene-free approach. Molecular Therapy 20 (10), S. 1953 - 1967 (2012)

Parsons, M. J.; Grimm, C.; Paya-Cano, J. L.; Fernandes, C.; Liu, L.; Philip, V. M.; Chesler, E. J.; Nietfeld, W.; Lehrach, H.; Schalkwyk, L. C.: Genetic variation in hippocampal microRNA expression differences in C57BL/6 J X DBA/2 J (BXD) recombinant inbred mouse strains. BMC Genomics 13, S. 476 (2012)